Holmium-166 (¹⁶⁶Ho) is used in nuclear medicine to deliver targeted radiation for treating liver tumors, a procedure called radioembolization. It’s administered as radioactive microspheres injected directly into the tumor. ¹⁶⁶Ho is a beta and gamma emitter, allowing it to destroy cancer cells with its beta radiation while its gamma emissions provide real-time imaging for precise placement and monitoring. This dual function enables personalized, image-guided treatment for liver malignancies, offering a potentially curative, minimally invasive option. The directory classifies it as a under development API with a mineral/inorganic source/manufacturing origin. Other names for this substance include UNII-QVC0N62WQE and Holmium chloride (166HoCl3). Its PubChem CID is 72941737.
Holmium chloride ho-166
| CAS No | 183139-18-6 |
|---|---|
| Molecular Formula | Cl3Ho |
| Molecular Weight | 272.29 g/mol |
| Synonyms | holmium-166(3+);trichloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Holmium-166 (¹⁶⁶Ho) is used in nuclear medicine to deliver targeted radiation for treating liver tumors, a procedure called radioembolization. It's administered as radioactive microspheres injected directly into the tumor.
The listed CAS number is 183139-18-6.
The listed molecular formula is Cl3Ho.
The listed molecular weight is 272.29 g/mol.
holmium-166(3+);trichloride.
The source lists UNII-QVC0N62WQE and Holmium chloride (166HoCl3).